February 25, 2016
February 25, 2016 – Vancouver, BC, Canada
The Vancouver Sun recently featured Precision NanoSystems in the health section to highlight the NanoAssemblr Platform as the next generation manufacturing platform for nanomedicines.
Randy Shore of the Vancouver Sun writes, “Using the unique physics of fluids at the nano-scale, the NanoAssemblr combines active ingredients — such as therapeutic strands of DNA or RNA — with complementary particles such as fatty molecules to form a kind of armoured transport. The active ingredients are encapsulated until they reach their target.”
Read the full article and view the interview with Precision NanoSystems’ CEO and co-founder, James Taylor.
News Article
Jul 10, 2017
Join Precision NanoSystems for its second annual nanomedicines symposium, entitled Nanomedicines: enabling new therapeutic modalities, on the 15th of July in Boston, MA. Following the success of last year’s inaugural event, the symposium will...
Press Release
Feb 28, 2013
Precision NanoSystems, Inc. (PNI), a privately held biotechnology company developing proprietary microfluidic-based manufacturing technology for the use and development of cutting edge nanomedicines, today announced completion of its initial extern...